Chanson International clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Chanson International Holding
CHSN · NASDAQ · USD · Market cap $2M · 497 employees
Chanson International Holding manufactures and sells a range of bakery products, seasonal products, and beverage products for individual and corporate customers in the People's Republic of China, Cayman Islands, and the…
Not yet scoredPrice as of 29 Oct 2026Daily close, not a live quote
Screened 2026-10-29 · the tape above runs as of 16:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price1.17 USD at the 29 Oct 2026 close
- Ethical screenNot yet scored
- Last reviewed29 Oct 2026 (1 days ago)
A summary of the dated readings below, not a live quote and not advice.
What this means: price 1.17 against the desk's fair-value range, over the last year.
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Chanson International Holding holds its Markup at $1.17. Consolidating, no directional conviction, held for 76 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 76 days |
| Price at the screen | $1.17 |
| Valuation | 0.36 trailing · N/A forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | -4.40 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Revenue purity | 3.97% | Below 5% | Only 4.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Chanson International clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-10-29. It updates when the underlying figures move, and past reads are kept below.
We do not yet have the financial statements needed to run the debt, cash, receivables and income screens for Chanson International, so it is not scored yet.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
The Business, in Plain Words| Trailing P/E | 0.4xvery cheap relative to earnings |
| EPS, trailing | 3.00 |
| Revenue growth | -10.3%revenue is shrinking |
| Profit margin | 1.0%barely profitable |
| Return on equity | 0.5%a modest return on shareholder capital |
| FCF yield | 163.88% |
| Debt to equity | 0.24minimal debt: a conservative balance sheet |
| Current ratio | 0.81below 1: short-term bills exceed liquid assets |
| Beta | -4.40barely tracks the market's swings |
| Short interest, float | 0.01% |
| 52-week range | 0.95 - 1,080.00 |
| Moat | NONE |
| Market cap | $2M |
| Employees | 497 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to China and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCHSN trades on NASDAQ (the company is based in China). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 40.5% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 100%. Our forward projection puts the odds of a 10% gain over the next month near 13%. Since the last review it dropped out of the Titan Ethical 500.
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 21.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 100%. Our forward projection puts the odds of a 10% gain over the next month near 13%.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 100%. Our forward projection puts the odds of a 10% gain over the next month near 13%.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 100%. Our forward projection puts the odds of a 10% gain over the next month near 13%.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 100%. Our forward projection puts the odds of a 10% gain over the next month near 13%.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 9.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 100%. Our forward projection puts the odds of a 10% gain over the next month near 13%.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 100%. Our forward projection puts the odds of a 10% gain over the next month near 13%.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $1.43 | -3.2% | · | $969 | -3.2% |
| 2 months | $249.00 | -99.4% | · | $6 | -99.4% |
| 3 months | $244.00 | -99.4% | · | $6 | -99.4% |
| 6 months | $214.00 | -99.4% | · | $7 | -99.4% |
| 1 year | $3,920.00 | -100.0% | · | $0 | -100.0% |
| 2 years | $18,960.00 | -100.0% | · | $0 | -100.0% |
| 3 years | $15,360.00 | -100.0% | · | $0 | -100.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CHSN does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.